Deaths from heart disease are rising for the first time in 50 years, according to the British Heart Foundation (BHF). The ...

Researchers analyzing data from 915 U.S. cities found that both obesity and impulsivity (measured by ADHD rates) are less ...

Advances in medical technology over the last 30 years have made it easier to detect and treat diabetes, leading to significant health improvements in people with the disease.

Research from the British Heart Foundation (BHF) has revealed the poor state of the nation's cardiological health but they ...

Various studies have pointed toward GLP-1 RAs causing mental health complications, such as anxiety and depression. The National Institutes of Health (NIH) published research in June 2024 that ...

The CBSE has also asked schools to submit a brief report along with photographs of these activities in PDF format.

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...

Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was ...

FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...